Ergotamine and rash papulosquamous Patient Reports February 11, 2012

Ergotamine Side Effects Report #4749872-1
Ergotamine side effect was reported by a Health Professional from UNITED KINGDOM on Aug 16, 2005. Male patient, 36 years of age, was diagnosed with migraine  and was treated with Ergotamine. After drug was administered, patient experienced the following side effects: blood immunoglobulin a increased, blood immunoglobulin e increased, pityriasis rosea, rash papulosquamous, rash pruritic, red blood cell sedimentation rate increased. Ergotamine dosage: 2 MG/D. During the same period patient was treated with ERGOTAMINE TARTRATE. Patient recovered.